摘要
随着疾病的进展,多数T2DM患者最终需要接受胰岛素治疗。目前,得到广泛公认的药物治疗途径是由口服降糖药经过单一胰岛素逐渐过渡至多次、多种胰岛素注射治疗。无论是在胰岛素起始治疗中,还是在强化胰岛素治疗(基础胰岛素+餐时胰岛素方案)中,地特胰岛素的疗效都得到了证实,且相对于其他基础胰岛素而言,具有低血糖风险小、增重少、个体血糖更加稳定的优势。
Most patients with T2DM would adopt insulin injection as the progression of disease. The widely accepted medication approach upgrades from oral anti diabetic drugs through single to multiple daily insulin doses. The efficacy of insulin detemir has been thoroughly verified by abundant experiments, both in insulin initiation and intensive insulin therapy （basal-bolus insulin therapy）. Compared with other basal insulin products, insulin detemir shows a lower risk of inducing hypoglycaemia and weight gain, and less intraindividual variability.
出处
《中国糖尿病杂志》
CAS
CSCD
北大核心
2013年第10期958-960,共3页
Chinese Journal of Diabetes
